Compare Fortinet Inc (FTNT) vs Vaxcyte Inc. Common Stock (PCVX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Fortinet Inc vs Vaxcyte Inc. Common Stock — how do they compare? Fortinet Inc trades at $182.97 (market cap $139.96B), while Vaxcyte Inc. Common Stock trades at $67.37 (market cap $10.51B). The key difference: Fortinet Inc is far larger — about 13.3× Vaxcyte Inc. Common Stock's market cap, and Fortinet Inc is more actively traded (2,774,680 versus 2,644,694). Which is the better fit depends on your goals — on Pluang, investors hold Fortinet Inc for 72 Days and Vaxcyte Inc. Common Stock for 0 Days on average.
| FTNT | PCVX | |
|---|---|---|
Market Cap | $139.96B | $10.51B |
Volume | 2,774,680 | 2,644,694 |
Sector | Technology | Health |
52-Week High | $194.75 | $73.82 |
52-Week Low | $75.23 | $40.32 |
Typical Hold Time | 72 Days | 0 Days |
Enterprise Value | $136.39B | $9.14B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Fortinet (FTNT) trades at $184.05, down 4.61% today, but maintains a bullish technical trend with strong fundamental performance. The company reported revenue of $6.80B in 2025 with a net income margin of 28.17%, and has consistently beaten earnings expectations in recent quarters. Recent news highlights its leadership in AI-driven cybersecurity and robust platform demand, with the stock nearing its 52-week high.
The outlook remains positive given strong earnings beats and raised 2026 guidance, though high valuation ratios (P/E 67.41) and competitive pressures pose risks. Analyst consensus is mixed with 42% buy ratings, but a $160.24 price target suggests caution relative to the current price. Institutional interest is growing, supporting momentum.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Fortinet Inc
Fortinet is a cybersecurity vendor that sells products, support, and services to small and midsize businesses, enterprises, and government entities. Its products include unified threat management appliances, firewalls, network security, and its security platform, Security Fabric. Services revenue is primarily from FortiGuard security subscriptions and FortiCare technical support. At the end of 2021, products were 38% of revenue and services were 62% of sales. The California-based company sells products worldwide.
Read more on FTNT →About Vaxcyte Inc. Common Stock
Vaxcyte, Inc. is a clinical-stage vaccine company that engineers protein-based vaccines to prevent bacterial diseases such as invasive pneumococcal disease, using its proprietary cell-free protein synthesis platform to develop candidates including the pneumococcal conjugate vaccines VAX-31 and VAX-24.
Read more on PCVX →
